590
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Does education influence the acceptability of faecal microbiota transplantation in colitis: A cross-sectional study

ORCID Icon, , & | (Reviewing Editor)
Article: 1233685 | Received 31 May 2016, Accepted 05 Sep 2016, Published online: 07 Oct 2016

References

  • Bassi, A., Dodd, S., Williamson P., & Bodger, K. (2004). Cost of illness of inflammatory bowel disease in the UK: A single centre retrospective study. Gut, 53, 1471–1478.
  • Carding, S., Verbeke, K., Vipond, D. T., Corfe, B. M., & Owen, L. J. (2015). Dysbiosis of the gut microbiota in disease. Microbial Ecology in Health and Disease, 26, 26191.
  • Colman, R. J., & Rubin, D. T. (2014). Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis. Journal of Crohn’s and Colitis, 8, 1569–1581.10.1016/j.crohns.2014.08.006
  • Dalziel, T. K. (1913). Chronic interstitial enteritis. British Medical Journal, 2, 1068–1070.
  • Gough, E., Shaikh, H., & Manges, A. R. (2011). Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent clostridium difficile infection. Clinical Infectious Diseases, 53, 994–1002.10.1093/cid/cir632
  • Hurst, A. F. (1931). A paper on ULCERATIVE COLITIS. British Medical Journal, 1, 693–694.10.1136/bmj.1.3668.693
  • Kahn, S. A., Vachon, A., Rodriquez, D., Goeppinger, S. R., Surma, B., Marks, J., & Rubin, D. T. (2013). Patient perceptions of fecal microbiota transplantation for ulcerative colitis. Inflammatory Bowel Diseases, 19, 1506–1513.10.1097/MIB.0b013e318281f520
  • Lepage, P., Leclerc, M. C., Joossens, M., Mondot, S., Blottière, H. M., Raes, J., et al. (2013). A metagenomic insight into our gut’s microbiome. Gut, 62, 146–158.10.1136/gutjnl-2011-301805
  • Li, N. (2013). A randomized, controlled, single-blind study of effects of pectin on flora intestinal colonization and maintenance after fecal transplantation to patients with inflammatory bowel disease. ClinicalTrials.gov. Identifier: NTC02016469. Estimated study completion February 2016.
  • Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., ... Lee, C. H. (2015). Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology, 149, 102–109.e6.10.1053/j.gastro.2015.04.001
  • Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., … Kaplan, G. G. (2012). Increasing incidence and prevalence of the inflammatory bowel diseases with time based on systematic review. Gastroenterology, 142, 46–54. doi:10.1053/j.gastro.2011.10.001
  • NICE guidelines. (2014). Faecal microbiota transplant for recurrent clostridium difficile infection: Consultation document. Retrieved June 6, 2014, from http://www.nice.org.uk/guidance/index.jsp?action=article&o=65569
  • Paramsothy S. (2013). Faecal microbiota transplantation for chronic active ulcerative colitis - A randomised double blind controlled study of efficacy & safety. ClinicalTrials.gov. Identifier: NCT01896635. Estimated study completion August 2016..
  • Ponsioen C. (2012). Transplantation of Faeces in Ulcerative Colitis; Restoring Nature’s Homeostasis (TURN). ClinicalTrials.gov. Identifier: NCT01650038. Estimated study completion December 2014..
  • Rossen, N. G., Fuentes, S., van der Spek, M. J., Tijssen, J. G., Hartman, J. H. A., Duflou, A., ... Ponsioen, C. Y. (2015). Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology, 149, 110–118.e4.10.1053/j.gastro.2015.03.045
  • Rossen, N. G., MacDonald, J. K., de Vries, E. M., D’Haens, G. R., de Vos, W. M., Zoetendal, E. G., & Ponsioen, C. Y. (2015). Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review. World Journal of Gastroenterology, 21, 5359–5371.10.3748/wjg.v21.i17.5359
  • Shi, Y., Dong, Y., Huang, W., Zhu, D., Mao, H., Su, P., & Singh, U. P. (2016). Fecal microbiota transplantation for ulcerative colitis: A systematic review and meta-analysis. PLOS ONE, 11, e0157259.10.1371/journal.pone.0157259
  • Smith, R. S., Bloomfield, S. F., & Rook G. A. (2012). The hygiene hypothesis and its implications for home hygiene, lifestyle and public health. International Scientific Forum on Home Hygiene. http://www.ifh-homehygiene.org
  • Marcus D., & Focht, G. (2013). Manipulating the microbiome in IBD by antibiotics and fecal microbiota transplantation (FMT): A randomized controlled trial. ClinicalTrials.gov. Identifier: NCT02033408 Estimated study completion January 2017.
  • UK Inflammatory Bowel Disease Audit 3rd Round. (2011). Executive summary report of the results for the national organisational audit of adult inflammatory bowel disease services in the UK. London: Royal College of Physicians.
  • Wilks, S. (1859). Morbid appearances in the intestines of Miss Bankes. London Medical Gazette, 2, 264–265.
  • Youngster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014). Oral, capsulized, frozen fecal microbiota transplantation for relapsing clostridium difficile infection. JAMA, 312, 1772–1778.10.1001/jama.2014.13875
  • Zipursky, J. S., Sidorsky, T. I., Freedman, C. A., Sidorsky, M. N., & Kirkland, K. B. (2012). Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent clostridium difficile infection. Clinical Infectious Diseases, 55, 1652–1658.10.1093/cid/cis809
  • Zipursky, J. S., Sidorsky, T. I., Freedman, C. A., Sidorsky, M. N., & Kirkland, K. B. (2014). Physician attitudes toward the use of fecal microbiota transplantation for the treatment of recurrent clostridium difficile infection. Canadian Journal of Gastroenterology and Hepatology, 28, 319–324.10.1155/2014/403828